Vicore Pharma Holding AB

VCRE · NASDAQ

$9.38−$0.94 (−9.11%)TodayMarket closed ·
Prev close $10.32

About VCRE

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

Employees
37
Headquarters
Stockholm, Vastra Gotalands
Listed
Dec 10, 2015
Sector
Health Care
Industry
Biotechnology

Leadership

Vicore Pharma Holding AB executives
NameTitleSince
Hans Schikan—2018
Ahmed Mousa——
Hans Jeppsson——
Nina Carlen——
Johan Raud——
Megan Richards——
Helen Barker——
Mikael Nygard——
Elin Rosendahl——
Jimmie Hofman——
Johanna Graens——
Bertil Lindmark——
Asa Magnusson——
Jessica Shull——
Yasir Al Wakeel——
Ann Barbier——
Elisabeth Bjork——
Michael Buschle——
Jacob Gunterberg——
Heidi Hunter——

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.